Related Experiment Video
Updated: Jun 7, 2025

Methods for Detecting Cough and Airway Inflammation in Mice
Published on: August 2, 2024
The Clinical Approach to Chronic Cough
Imran Satia1, Wafa Hassan2, Lorcan McGarvey3
1Department of Medicine, McMaster University, Hamilton, ON, Canada; Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, Canada.
Chronic cough affects 10% of people, impacting quality of life. New treatments target cough hypersensitivity, offering hope for refractory chronic cough (RCC) management.
Area of Science:
- Respiratory Medicine
- Neurology
- Pharmacology
Background:
- Chronic cough affects 10% of the population, significantly impairing quality of life.
- Refractory chronic cough (RCC) presents a major clinical challenge.
- Cough hypersensitivity syndrome, a neuropathic mechanism, is increasingly recognized in RCC.
Purpose of the Study:
- To review current investigations into the pathophysiology of chronic cough and RCC.
- To summarize emerging management strategies for chronic cough and RCC.
- To highlight the "treatable trait" approach and novel therapeutic targets.
Main Methods:
- Review of current scientific literature on chronic cough and RCC.
- Analysis of emerging treatment modalities, including neuromodulators and receptor antagonists.
- Discussion of the "treatable trait" approach in managing chronic cough.
Main Results:
- The "treatable trait" approach is gaining traction for managing chronic cough.
- Neuropathic mechanisms and cough hypersensitivity are key in RCC.
- New treatments, including P2X3 receptor antagonists, show promise but patient responses vary.
Conclusions:
- Understanding cough hypersensitivity is crucial for managing RCC.
- Targeting neuronal pathways offers new therapeutic avenues.
- Further research is needed to optimize treatment strategies for RCC due to variable patient responses.
More Related Videos
05:43Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
Published on: January 10, 2025
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...